Serial Number | 79384444 |
Word Mark | DEXOLIGO |
Filing Date | Wednesday, August 2, 2023 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Wednesday, November 6, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 26, 2024 |
Goods and Services | Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA for use in the treatment of cancer, hepatitis, neurodegenerative diseases, neurological diseases, hemophilia, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, rare bleeding disorders, iron overload disorders, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, chronic liver infection, anemia, myeloproliferative disorders, auto-immune disorders, chronic kidney diseases, obesity, type 2 diabetes, metabolic syndrome and related conditions, thrombocythemia, gout |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 8, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Dexcel Pharma Technologies Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | IL |
Event Date | Event Description |
Thursday, December 7, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, December 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, December 12, 2023 | APPLICATION FILING RECEIPT MAILED |
Wednesday, April 3, 2024 | ASSIGNED TO EXAMINER |
Monday, April 8, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, April 9, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, April 24, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, April 24, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, May 14, 2024 | REFUSAL PROCESSED BY IB |
Tuesday, October 15, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, October 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, October 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, October 31, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |